CDMRP Neurofibromatosis Early Investigator Research Award
ID: 355149Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355149
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Neurofibromatosis Early Investigator Research Award, aimed at supporting innovative research on neurofibromatosis (NF) and related disorders. This grant opportunity is designed for early-stage investigators, including those in postdoctoral training or medical residency with up to four years of postdoctoral experience, who must work under the guidance of a designated mentor experienced in NF research. With an estimated total program funding of $640,000 and the expectation of awarding two grants, applicants can request up to $200,000 over a two-year period to address critical needs within the NF community. Key deadlines include a pre-application submission by September 12, 2024, and a full application due by October 3, 2024; for further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524NFRPEIRA_GG.pdf
    The Department of Defense's (DOD) FY24 Neurofibromatosis Early Investigator Research Award aims to support novel research on neurofibromatosis (NF) and related disorders. This program intends to foster high-impact, innovative studies that enhance understanding, diagnosis, and treatment of NF1, NF2, and schwannomatosis, with a funding allocation of $25 million for FY24. Early-stage investigators in postdoctoral training or medical residency with up to four years of postdoctoral experience are eligible to apply, provided they have a designated mentor experienced in NF research. The funding supports research projects with a maximum budget of $200,000 over two years and emphasizes collaborative and interdisciplinary approaches, with a focus on addressing critical needs within the NF community. Applications must align with specified Areas of Emphasis and successfully pass two-tiered peer and programmatic review processes. Key submission dates include a pre-application deadline of September 12, 2024, and a full application deadline of October 3, 2024. This initiative reflects the DOD’s commitment to addressing health issues pertinent to Service Members, Veterans, and the public through scientific advancement in NF research.
    Similar Opportunities
    DOD Glioblastoma, Transformative Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Glioblastoma Transformative Consortium Award, aimed at advancing research to improve outcomes for glioblastoma patients. This grant seeks proposals for innovative, multidisciplinary projects that collectively address a central hypothesis, requiring collaboration among at least four distinct projects and the inclusion of a consumer advocate. With an estimated total program funding of $9 million, the application process includes a pre-application deadline of December 23, 2024, and a full application deadline of January 13, 2025. Interested applicants can reach the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) to support promising candidates in mentored postdoctoral training focused on neurological research. This grant program encourages applications from individuals who are within 12 months prior to or after starting a postdoctoral position, emphasizing innovative research ideas without the need for preliminary data. The funding aims to enhance the development of independent researchers through rigorous training and strong mentorship, covering stipends, tuition, and fees for a maximum of three years. Interested applicants can find more information and application details at the NIH Grants website, with a submission deadline of January 7, 2028, and inquiries directed to grantsinfo@nih.gov.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support rehabilitation scientists in establishing independent research careers. This grant aims to fund basic and clinical research projects that align with the mission of the National Center for Medical Rehabilitation Research (NCMRR), encouraging innovative studies in areas such as secondary data analysis, translational research, and the development of new technologies. The total estimated program funding is $200,000, with an award ceiling of $200,000, and applications are due by January 7, 2028. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details.
    NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is inviting applications for the Biobehavioral Research Awards for Innovative New Scientists (BRAINS), aimed at supporting early-stage investigators in launching innovative research focused on mental disorders. This program seeks to fund high-risk, high-reward projects that may not have the preliminary data typically required for traditional funding, with an emphasis on advancing understanding and treatment of mental health issues. Eligible applicants include tenure-track faculty designated as Early Stage Investigators by NIH, and the grant provides up to $500,000 per year for a maximum of five years, with a total of approximately $3 million allocated annually for 6-8 awards. Interested parties can find more information and apply by June 20, 2025, and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support early-stage rehabilitation scientists in establishing independent research careers. This grant aims to fund a variety of research projects, including secondary data analysis, methodology development, and translational research, particularly those that can generate preliminary data for future R01 applications. The initiative is crucial for fostering innovative rehabilitation research and enhancing the diversity of research talent in the biomedical field. The maximum funding amount is $200,000 over two years, with applications due by May 8, 2026. Interested applicants can find more information and application details at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the "Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)." This program aims to support innovative research projects focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD), specifically targeting early-stage and diverse researchers who have not previously received significant NIH funding in this field. The initiative is designed to generate pilot data that can lead to larger funding applications, thereby enhancing research capabilities and workforce diversity in biomedical research. Grants of up to $100,000 per year for two years are available, with the application process opening on January 16, 2025, and the closing date set for March 16, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01), aimed at enhancing diversity within the neuroscience research workforce. This grant supports junior faculty from underrepresented backgrounds who are in the first three years of a tenure-track position, providing them with research cost support, protected research time, and mentorship as they lead independent clinical trials or feasibility studies. The funding mechanism allows for up to five years of support, with annual salary contributions of up to $95,000 (or $125,000 for licensed clinical degree holders) and additional research development costs of $100,000 per year. Interested applicants should note that the application opens on September 12, 2024, with submission deadlines primarily in October and February each year until 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for research focused on the neurological effects of infection-associated chronic illnesses, including conditions like Neuro-PASC, post-treatment Lyme Disease, and ME/CFS. This initiative aims to promote understanding of the neuropsychiatric manifestations of these illnesses, with a particular interest in projects that explore common mechanisms across multiple conditions, although applications can focus on individual illnesses as well. The anticipated funding amount for this grant is up to $500,000, with the NOFO expected to be published in Fall 2024 and applications due in Winter 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of February 3, 2025, with awards expected to be made by December 1, 2025.